header
 

GcMAF immunotherapy

The GcMAF is an immunotherapy which is often used in strong diseases like cancer. GcMAF activated immune system and helps the body to recognize cancer cells and fight against them.

Our clinic in Germany fulfill the legal guidelines for GcMAF immunotherapy. GcMAF fall under the Medicines Act, as it applies only intravenously. In § 13 par. 2 of the German Medicines Act has stipulated that the GcMAF drug should only be used by therapists who guided the preparation of the active ingredient in the laboratory of themself. Doctor Gerhard Siebenhüner subject in his GcMAF production the controle of the  guidelines of Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP). Doctor Dr. med. Siebenhüner reconstituted GcMAF distinguished by outstanding, laboratory tested quality. The high purity the quality of the GcMAF substance leads to a good immunotherapy.

The natural active ingredient of GcMAF is an endogenous substance (Gc macrophage activating factor) and resulting of that the pure formulation leads to no side effects.

GcMAF is administered only by intravenous injection, because scientifically proven for subcutaneous or intramuscular injections are not exist. An oral intake of GcMAF`s leads to complete degradation of the active substance on the first pass effect of the digestive system. The dosage of the immune treatment is individually adapted to the patient. Often good results of GcMAF treatment in a 5- week concept.

GcMAF is used in:

  •  ALS, AIDS
  • Alzheimer
  • autism
  • cancer
  • colitis
  • Crohn’s disease
  • fibromyalgia
  • HIV
  • Kidney CKD
  • cirrhosis
  • LMBBS
  • ME / CFS
  • MS
  • Parkinson
  • psoriasis
  • inflammation
  • viral and bacterial infections